siamycin II: isolated from Streptomyces; amino acid sequence in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16130326 |
| MeSH ID | M0248366 |
| Synonym |
|---|
| siamycin ii |
| (2s)-2-[[(2s)-2-[[(2-amino-2-oxo-ethyl)-benzyl-(hydroxymethyl)-[(4-hydroxyphenyl)methyl]-isobutyl-isopropyl-dimethyl-bis[(1s)-1-methylpropyl]-nonadecaoxo-[?]carbonyl]amino]-3-phenyl-propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid |
| wfcviaygcgafdncsgiglc |
| bmy-29303 |
| 164802-69-1 |
| l-tryptophan, l-cysteinyl-l-leucylglycyl-l-isoleucylglycyl-l-seryl-l-cysteinyl-l-asparaginyl-l-alpha-aspartyl-l-phenylalanyl-l-alanylglycyl-l-cysteinylglycyl-l-tyrosyl-l-alanyl-l-isoleucyl-l-valyl-l-cysteinyl-l-phenylalanyl-, cyclic (9-1)-peptide, cyclic |
| bmy 29303 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||